Low molecular weight dextran: a continuing cause of acute renal failure.
作者信息
Feest T G
出版信息
Br Med J. 1976 Nov 27;2(6047):1300. doi: 10.1136/bmj.2.6047.1300.
Abstract
摘要
相似文献
1
Low molecular weight dextran: a continuing cause of acute renal failure.低分子量右旋糖酐：急性肾衰竭的持续病因。
Br Med J. 1976 Nov 27;2(6047):1300. doi: 10.1136/bmj.2.6047.1300.
2
Acute oliguric renal failure associated with low-molecular-weight dextran.
Bol Asoc Med P R. 1972 Jan;64(1):1-4.
3
[Acute renal failure caused by dextran of low molecular weight].
Rev Clin Esp. 1970 Jan 31;116(2):169-72.
4
[Case of acute kidney failure induced low-molecular weight dextran effectively treated by plasma exchange].[血浆置换有效治疗低分子右旋糖酐所致急性肾衰竭病例]
Nihon Naika Gakkai Zasshi. 1994 Feb 10;83(2):294-5.
5
Acute renal failure induced by low molecular weight dextran.
Aust N Z J Med. 1984 Oct;14(5):688-9. doi: 10.1111/j.1445-5994.1984.tb05034.x.
6
Renal failure associated with low-molecular-weight dextran infusion.与输注低分子量右旋糖酐相关的肾衰竭。
Br Med J. 1966 Sep 24;2(5516):737-9. doi: 10.1136/bmj.2.5516.737.
7
Renal failure and low-molecular-weight dextran.肾衰竭与低分子量右旋糖酐
Br Med J. 1967 Mar 11;1(5540):635. doi: 10.1136/bmj.1.5540.635-c.
8
Plasma exchange in the treatment of acute renal failure due to low molecular-weight dextran.
Mayo Clin Proc. 1980 Jun;55(6):387-9.
9
Renal toxicity of low molecular weight dextran: a review of the literature.
J La State Med Soc. 1974 Dec;126(12):425-7.
10
Dextran-40, acute renal failure, and elevated plasma oncotic pressure.
N Engl J Med. 1988 Jan 28;318(4):252-4. doi: 10.1056/NEJM198801283180413.
引用本文的文献
1
Association Between Aortic Wall Parameters on Multidetector Computed Tomography and Ruptured Plaques By Nonobstructive General Angioscopy.多排螺旋 CT 主动脉壁参数与非阻塞性全血管镜检查的破裂斑块的关系。
J Am Heart Assoc. 2024 Mar 19;13(6):e033233. doi: 10.1161/JAHA.123.033233. Epub 2024 Mar 18.
2
Low-molecular-weight dextran for optical coherence tomography may not be protective against kidney injury in patients with renal insufficiency.用于光学相干断层扫描的低分子量右旋糖酐可能无法预防肾功能不全患者的肾损伤。
World J Nephrol. 2021 Mar 25;10(2):8-20. doi: 10.5527/wjn.v10.i2.8.
3
The effects of synthesis method on the physical and chemical properties of dextran coated iron oxide nanoparticles.合成方法对葡聚糖包覆氧化铁纳米颗粒物理化学性质的影响。
Mater Chem Phys. 2015 Jun 15;160:177-186. doi: 10.1016/j.matchemphys.2015.04.022.
4
Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?羟乙基淀粉作为急性肾衰竭的一个风险因素：是否需要改变临床实践？
Drug Saf. 2002;25(12):837-46. doi: 10.2165/00002018-200225120-00002.
5
[Toxic nephropathies (author's transl)].[中毒性肾病（作者译）]
Klin Wochenschr. 1980 Feb 1;58(3):105-16. doi: 10.1007/BF01477267.
6
Intravenous volume replacement: indications and choices.静脉补液：适应证与选择
Br Med J (Clin Res Ed). 1988 May 21;296(6634):1422-3. doi: 10.1136/bmj.296.6634.1422.
7
Blood and plasma substitutes--plasma expansion and oxygen transport properties.血液及血浆代用品——血浆扩容及氧运输特性
West J Med. 1985 Aug;143(2):202-6.
8
Anaphylactoid reactions to dextran 70.对右旋糖酐70的类过敏反应。
Br Med J. 1977 Dec 3;2(6100):1480. doi: 10.1136/bmj.2.6100.1480-b.
9
Drug-induced renal disease.药物性肾病
Drugs. 1979 Nov;18(5):377-91. doi: 10.2165/00003495-197918050-00003.
本文引用的文献
1
Acute renal failure after administration of low-molecular-weight dextran.
N Engl J Med. 1967 Nov 23;277(21):1113-8. doi: 10.1056/NEJM196711232772103.
2
Renal failure after the administration of dextran 40.
Surg Gynecol Obstet. 1970 Oct;131(4):661-8.
3
Studies on renal tubular morphology and toxicity after large doses of dextran 40 in the rabbit.大剂量右旋糖酐40对兔肾小管形态及毒性的研究。
Lab Invest. 1970 Apr;22(4):355-60.
4
Intermittent low molecular weight dextran infusions in the management of ischemic skin disorders.
Bibl Anat. 1973;11:359-63.
Zotero 插件